Skip to main content
Membership NewsMembership News Archive

GAMBICA and BIVDA global conference partnership

BIVDA and GAMBICA are joining forces to strengthen their presence at the world’s largest laboratory and diagnostic trade shows. Our two trade associations will co-present UK pavilions at upcoming global events such as ADLM Clinical Congress in Chicago and MEDICA in Germany, in 2024. We are delighted to partner with GAMBICA to bring our collective expertise in laboratory technology and…
Dawn
March 13, 2024
Membership NewsMembership News Archive

Request for Medical Equipment Donations for Ukraine

BIVDA have been contacted following conversations between Ukraine’s First Lady, Olena Zelenska, and the UK’s Secretary of State for Business and Trade, Kemi Badenoch. The conflict in Ukraine, like all wars, impacts heavily on children and civilians as well as those that fight.  Mrs Zelenska’s foundation is seeking donations of medical and laboratory equipment to assist with the reconstruction of…
Dawn
March 13, 2024
Membership NewsMembership News Archive

Helen interviewed by Genowrite ahead of London Biotechnology Show

BIVDA Interim Chief Executive, Helen Dent, was interviewed for Genowrite by Paul Naphtali. Helen spoke about the important role of IVDs and how BIVDA works to develop a thriving UK market for members. To achieve this, Helen touched upon the four key areas of focus which drives BIVDA activities, including influencing key stakeholders and encouraging the appropriate use and increased…
Dawn
March 13, 2024
Membership NewsMembership News Archive

BIVDA respond to election-year Budget

BIVDA note with interest today’s election-year Budget. As expected, the Budget was light on impact for the life sciences and medical diagnostic sectors and focussed on election-year issues. Funding £45m into medical research, including £3m ringfenced for cancer, is welcome but relatively low impact. An investment of £650m into the Cambridge Biomedical Campus and a vaccine hub in Speke by…
Ben Kemp
March 6, 2024
Membership NewsMembership News Archive

Commercial partner needed for novel sudden cardiac death diagnostic test

Dr Angeliki Asimaki, Senior Lecturer in Sudden Death based at St George’s, University of London, is seeking a commercial partner or support organisation for her test to diagnose risk of sudden cardiac death. Dr Asimaki studies a disease called arrhythmogenic cardiomyopathy, one of the major causes of sudden death in all populations of the world. Currently, there is no gold…
Ben Kemp
March 6, 2024
Membership NewsMembership News Archive

Barclays Eagle Labs funding and support programmes

Barclays Eagle Labs, who are partnered with BIVDA’s Springboard programme, have two programmes open which may be of interest to BIVDA members: Funding Readiness Programme The Funding Readiness Programme helps companies to improve their knowledge of the funding landscape, learn about the available innovation grant funds, how to develop a compelling grant application, and understand how to plan, market and…
Ben Kemp
March 6, 2024
Membership NewsMembership News Archive

Free hybrid event: Novel Diagnostics for Infectious Diseases, 25-26 March

Head to the Royal Society, or watch online, for this free event, which will examine common challenges shared by diagnostics developers. It has been organised by Imperial College London’s Institute of Infection, B2B2B Network, London In Vitro Diagnostics Co-operative and NIHR Biomedical Research Centre. Through presentations and panel discussions, attendees will explore topics such as Technologies and Challenges, Regulatory and Adoption…
Ben Kemp
March 6, 2024
Membership NewsMembership News Archive

BIVDA attends the Academy of Medical Sciences FORUM workshop on early detection of neurodegenerative diseases

Last week, BIVDA’s Innovation Programme Lead Lucy Lehane, attended a workshop focussing on the early detection of neurodegenerative diseases in primary care and the community. The Academy of Medical Sciences, Alzheimer’s Research UK, and Alzheimer’s Society jointly hosted the workshop, and the audience included a number of people with lived experience of neurodegenerative conditions alongside experts from across neurology, brain…
Ben Kemp
March 6, 2024